Gene therapy for sickle cell disease shows strong clinician support but faces barriers in referral practices, knowledge, and ...

Full 12-month data from Ocugen’s phase 2 eye disease gene therapy show the therapy significantly reduces the size of lesions, ...

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a ...

Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role ...

Prof. Walter H. Gunzburg, Chairman of Austrianova, said: "MCBs are a prerequisite for the production of Cell-in-a-Box® encapsulated cell products. They provide the foundation for sustainable ...

Nucleic acids such as DNA and RNA play a central role in gene therapies and vaccines. They store and transmit biological ...

A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by pinpointing new connections between people's genes, disease risk and medicine ...

BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ...

A growing body of evidence suggests that a single gene, APOE, may play a far more dominant role in Alzheimer’s disease than ...

Once-lethal insecticides now require concerningly high concentrations to effectively kill mosquitoes. Some mosquitoes are ...

A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...